• Media type: E-Article
  • Title: SCID genotype and 6-month posttransplant CD4 count predict survival and immune recovery
  • Contributor: Haddad, Elie; Logan, Brent R.; Griffith, Linda M.; Buckley, Rebecca H.; Parrott, Roberta E.; Prockop, Susan E.; Small, Trudy N.; Chaisson, Jessica; Dvorak, Christopher C.; Murnane, Megan; Kapoor, Neena; Abdel-Azim, Hisham; Hanson, Imelda C.; Martinez, Caridad; Bleesing, Jack J. H.; Chandra, Sharat; Smith, Angela R.; Cavanaugh, Matthew E.; Jyonouchi, Soma; Sullivan, Kathleen E.; Burroughs, Lauri; Skoda-Smith, Suzanne; Haight, Ann E.; Tumlin, Audrey G.; [...]
  • Published: American Society of Hematology, 2018
  • Published in: Blood, 132 (2018) 17, Seite 1737-1749
  • Language: English
  • DOI: 10.1182/blood-2018-03-840702
  • ISSN: 0006-4971; 1528-0020
  • Origination:
  • Footnote:
  • Description: Key Points The genetic cause of SCID impacts on survival and immune reconstitution and should be considered in tailoring HCT for individual patients. Total and naive CD4+ cell counts in SCID patients 6 and 12 months post-HCT predict long-term survival and sustained immune reconstitution.
  • Access State: Open Access